IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
May 17, 2022 8:05am EDT

IMV Inc. to Present at the H.C. Wainwright Global Investment Conference

May 13, 2022 7:05am EDT

IMV Inc. Announces First Quarter 2022 Financial and Operational Results

May 06, 2022 7:05am EDT

IMV Inc. to Announce First Quarter 2022 Results and Host a Conference Call and Webcast on May 13, 2022

Apr 28, 2022 7:05am EDT

IMV’s Lead Compound to Be Showcased in Two Presentations at the 2022 ASCO Annual Meeting

Apr 22, 2022 7:05am EDT

IMV Inc. Names Michael P. Bailey Chairman of The Board

Apr 08, 2022 5:00pm EDT

IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting

Apr 06, 2022 7:05am EDT

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

Apr 04, 2022 7:05am EDT

IMV Inc. to Present at Two Upcoming Investor Conferences

Mar 17, 2022 7:05am EDT

IMV Inc. Announces Fourth Quarter and Full Year 2021 Financial and Operational Results

Mar 10, 2022 7:05am EST

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2021 Results and Host a Conference Call and Webcast on March 17, 2022

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...40
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap